Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Tübingen, Universität Tübingen, Dissertation, 2019
- Schlagwort
-
Liver--Cancer
Inhibition
Apoptosis
Tumors--Growth
Leberzellkrebs ; Zellzyklus ; Apoptosis
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wer)
-
Universitätsbibliothek Tübingen
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
-
Plentz, Ruben
- URN
-
urn:nbn:de:bsz:21-dspace-980801
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xing, Jun
- Plentz, Ruben
- Universitätsbibliothek Tübingen
Entstanden
- 2021
Ähnliche Objekte (12)
Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition
Glycine - tumor growth inhibition in experimental hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
Water-soluble pristine C60 fullerene inhibits liver alterations associated with hepatocellular carcinoma in rat
Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma?
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition
Glycine - tumor growth inhibition in experimental hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
Water-soluble pristine C60 fullerene inhibits liver alterations associated with hepatocellular carcinoma in rat
Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma?
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition
Glycine - tumor growth inhibition in experimental hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
Water-soluble pristine C60 fullerene inhibits liver alterations associated with hepatocellular carcinoma in rat
Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma?
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma